T Stamp Inc. Form 8-K Summary
Business Context and Reporting Period
T Stamp Inc. (NASDAQ: IDAI), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on October 27, 2024. The report details a material definitive agreement and the subsequent unregistered sale of equity securities involving DQI Holdings, Inc. ("DQI").
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of Class A Common Stock.
- Shares Issued: 1,363,636.36 shares.
- Price Per Share: $0.22.
- Total Proceeds: $300,000 in cash.
- Closing Date: October 28, 2024.
- Registration Status: Unregistered sale pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D.
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics for the reporting period.
Material Changes and Agreements
The primary material change is the entry into a Securities Purchase Agreement (SPA) and a Registration Rights Agreement with DQI. Key terms include:
- Registration Rights: T Stamp Inc. must file a registration statement (Form S-3 or appropriate alternative) to register the shares for resale by DQI.
- Conditions for Effectiveness: The registration statement becomes effective 5 days after stockholder ratification of a prior SPA dated July 13, 2024, which involved the sale of 4,597,701 shares to DQI.
- Timeline: The company must obtain SEC effectiveness within 45 days of filing, or 75 days in the event of a full SEC review.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the SPA and the associated registration obligations. The filing highlights the dependency on stockholder ratification of the July 2024 agreement to trigger the registration effectiveness timeline. No specific forward-looking guidance, risk factors, or contingencies beyond the standard closing conditions and registration timelines were detailed in this specific report.
Investor Verification Checklist
- Verify the status of stockholder ratification for the July 13, 2024 Securities Purchase Agreement with DQI.
- Confirm the filing date and effectiveness status of the required Form S-3 registration statement for the resale of the 1,363,636.36 shares.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) and Registration Rights Agreement (Exhibit 10.2) for additional covenants or conditions.
- Assess the cumulative impact of the July 2024 and October 2024 share issuances on existing shareholder dilution.